The 4th Coral Gables Symposium
Biltmore Hotel, Miami, FL
October 5-7, 2016
This years´ Coral Gables Symposia will provide a unique forum for thought leaders to address the principal concerns regarding immunogenicity and the patient. In particular, how an understanding of the immune response to biopharmaceuticals can benefit the patient both in terms of optimizing therapy, mitigating side effects, and improving outcome.
Anaphylaxis, known to be a sudden and potentially life-threatening allergic reaction, seems to be increasing among children, according to a new study led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC). The findings, published this week in theJournal of Allergy and Clinical Immunology (JACI), reveal that the percentage of emergency department (ED) visits due to anaphylaxis doubled over a four-year period based on data collected from the Montreal Children’s Hospital of the MUHC (MCH-MUHC). Read More
(Source: https://www.mcgill.ca/newsroom/channels/news/increasing-cases-anaphylaxis-among-children-260563)
image credit: https://www.prettydesigns.com
USCALOOSA, Ala. — There’s no known cure for the common cold, but receiving multiple tattoos can strengthen your immunological responses, potentially making you heartier in fighting off common infections, according to research by a trio of University of Alabama scholars. Read More
(Source: https://uanews.ua.edu/2016/03/want-to-avoid-a-cold-try-a-tattoo-or-twenty-says-ua-researcher/)
IMAGE: A STUDY BY LJI RESEARCHERS IDENTIFIED A T CELL POPULATION THAT RENDERS NORMAL FOOD NON-ALLERGENIC. PHOTO CREDIT: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
LA JOLLA, CA–An estimated 15 million Americans suffer from food allergies, many of them children. These are non-trivial concerns, as food allergy or intolerance can cause symptoms ranging from a harmless skin rash to a potentially lethal anaphylactic shock. The good news is that many affected children outgrow their allergy, presumably as the immune system learns to tolerate food initially mistaken as “foreign”. Read more
(Source: https://www.eurekalert.org/pub_releases/2016-01/ljif-nsi012516.php)
.gif)
PVS-RIPO Virus
There has been much buzz about the recent studies performed at Duke University since it was featured on 60 minutes on March 29th. This research has been focused on genetically engineering the polio virus to use for therapy in patients with cancer, more specifically, glioblastoma. The basis of this experimental therapy surrounded the scientific hypotheses that viruses could target cancer with viruses. In fact, these are ideas that have been around for a hundred years or more. Scientists at Duke took the Polio virus and genetically modified it to remove the harmful sequence that causes paralysis and replaced it with a harmless cold virus sequence. This new polio virus (PVS-RIPO) was then injected directly into the brain of the patients in the clinical trial.
So far, their work has proven that this is very promising treatment for cancer patients because they were able to not only shrink the tumors in several patients in this study but also diminish them until they were completely cancer free. However, there were patients that were not so lucky and did pass away during the course of this clinical trial. The goal of this study was to determine the proper dosage of the virus and scientist did in fact gain valuable insight that will help to continue to prove that this immunotherapy and other like it.
Read more
image above from www.cancer.duke.edu
Related Products:
Immunology Assay Kits
Cancer Biomarkers Kits
Eagle Biosciences recently launched
new immunoaffinity columns from their partner, BioTez Berlin-Buch GmbH in
Germany.BioTez is an expert not only in
ELISAs but also immunoaffinity columns (IAC) with a strong focus on biotechnological
research and providing high quality products. Eagle’s partnership with BioTez began in the spring of this year
and has continued to be a fruitful relationship with new opportunities from
their continuous flow of innovative products.
“The immunoaffinity columns in this product
line offer excellent flow behavior, incredible robustness, and high permeability,
with no increased pressure required.”Dan Keefe, President of EagleBio commented, “We are pleased to be adding
more products from BioTez.”He
continued, “These columns offer many advantages and are manufactured using the
utmost quality in the areas of mycotoxin and vitamin analysis, two areas that
BioTez is highly specialized.”
These
products are currently for research use only. Check out the list below of new BioTez
immunoaffinity columns below. Visit the Eagle website www.EagleBio.com or
call 866-411-8023 for full details.
Fumonisin Immunoaffinity Column (3ml, 10 columns)
Aflatoxin Immunoaffinity Column (3ml, 10 columns)
Ochratoxin Immunoaffinity Column (3ml, 10 columns)
Vitamin B12 Immunoaffinity Column (3ml, 10 columns)
Folic Acid Immunoaffinity Column (3ml, 10 columns)
Biotin Immunoaffinity Column (3ml, 10 Columns)
Related Products:
Immunology Assay Kits
Vitamin Assay Kits
